Filing Details

Accession Number:
0001209191-21-056604
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 16:02:21
Reporting Period:
2021-09-15
Accepted Time:
2021-09-17 16:02:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189184 Jr F Thomas Kearns C/O Fibrogen, Inc.
409 Illinois St.
San Francsico CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-15 13,100 $11.58 39,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 110,000 Indirect By Trust
Common Stock 100,000 Indirect By LLC
Footnotes
  1. These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.
  2. Shares are held by Go Heels, LLC. The reporting person is Manager and Sole Member of Go Heels and has voting and investment control with respect to the shares held by Go Heels, LLC.